Supernus Pharmaceuticals ... In addition, the company develops ONAPGO, which received FDA approval, for the treatment of motor fluctuations in adults with advanced PD; SPN-817, a first-in-class ...

President and CEO of Supernus. “In addition, we are pleased to be bringing ONAPGO to market, another growth driver for our business. ONAPGO represents a novel approach for adults with Parkinson ...

As it continues to ramp up sales of its attention-deficit/hyperactivity disorder (ADHD) drug Qelbree, Supernus Pharmaceuticals is getting Busy to raise awareness of ...

The subdued stock price reaction suggests that Supernus Pharmaceuticals, Inc.'s (NASDAQ:SUPN) strong earnings didn't offer any surprises. Investors are probably missing some underlying factors ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Clearly, options traders are pricing in a big move for Supernus Pharmaceuticals shares, but what is the fundamental picture for the company? Currently, Supernus Pharmaceuticals is a Zacks Rank #3 ...

Busy Philipps partners with Supernus Pharmaceuticals to launch a campaign addressing ADHD in women, sharing her personal journey with Qelbree. Actress Busy Philipps has partnered with Supernus ...

Update 10.16 AM EST: Adds the Cantor Fitzgerald downgrade Supernus Pharmaceuticals (NASDAQ:SUPN) lost ~20% in the premarket on Wednesday after the neuro-focused biopharma said its depression ...

May 20, 2025 (GLOBE NEWSWIRE) -- Actress, author, podcaster, and mom, Busy Philipps, is stepping into an important new role as 'Ms. Represented' in partnership with Supernus Pharmaceuticals for a new ...